Chiome Bioscience

Chiome Bioscience PP&E per Employee

The PP&E per Employee of Chiome Bioscience (4583.T) as of Oct 30, 2026 is 49,734.69 JPY. In the previous year, PP&E per Employee was 85,693.88 JPY — a change of -41.96% (lower).

PP&E per Employee

49,734.69JPY

YoY

-41.96%

Last updated:

PP&E per Employee of Chiome Bioscience is 2022 49,734.69 JPY. PP&E per Employee of Chiome Bioscience was 2021 85,693.88 JPY. It decreases by -41.96% lower compared to the previous year.

The Chiome Bioscience PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2015
8.89 M JPY
Jan 1, 2016
720,734.69 JPY
Jan 1, 2017
468,673.47 JPY
Jan 1, 2018
325,510.20 JPY
Jan 1, 2019
226,673.47 JPY
Jan 1, 2020
146,040.82 JPY
Jan 1, 2021
85,693.88 JPY
Jan 1, 2022
49,734.69 JPY
The Chiome Bioscience PP&E per Employee history
YEARPP&E per EmployeeYoY
49,734.69JPY-41.96%
85,693.88JPY-41.32%
146,040.82JPY-35.57%
226,673.47JPY-30.36%
325,510.20JPY-30.55%
468,673.47JPY-34.97%
720,734.69JPY-91.89%
8.89 MJPY+9.46%
8.12 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Chiome Bioscience Stock analysis

What does Chiome Bioscience do? Chiome Bioscience, Inc. operates in Shibuya-Ku, Tokyo-To and generates revenue through two distinct business segments focused on antibody drug development. The Drug Discovery segment conducts research and development of specific antibodies based on new antigens and mechanisms, subsequently licensing these assets to pharmaceutical companies. This approach allows the firm to monetize its proprietary technology and scientific findings directly through licensing agreements. The Drug Discovery Support segment complements this by developing lead antibodies for therapeutic drugs in collaboration with pharmaceutical companies in Japan and overseas. Through these partnerships, the company provides specialized development services that support the creation of new therapeutic agents. Both segments leverage the company's Autonomous Diversifying Library (ADLib) system to facilitate the creation and refinement of antibody drugs for its clients. Chiome Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Chiome Bioscience stock

PP&E per Employee of Chiome Bioscience is 49,734.69 JPY in 2022.

PP&E per Employee of Chiome Bioscience changed from 85,693.88 JPY to 49,734.69 JPY, representing a -41.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Chiome Bioscience since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Chiome Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Chiome Bioscience

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Chiome Bioscience